Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 2/2021

01-02-2021 | Systemic Sclerosis | Clinical Image

Scleroderma-associated cutaneous calcinosis: a remarkable regression post stem cell transplantation

Authors: Abuelmagd Abdalla, Muhammad Khalid, Qasim Ishaq, Suzanne Donnelly

Published in: Clinical Rheumatology | Issue 2/2021

Login to get access

Excerpt

We present a case of a woman with scleroderma with severe calcinosis that had regressed dramatically following stem cell transplant. This is a rare and novel finding with very few reports available in the literature. …
Literature
1.
Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 65(11):2737–2747CrossRef
2.
Daoussis D, Antonopoulos I, Liossis SNC, Yiannopoulos G, Andonopoulos AP (2012) Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature. Semin Arthritis Rheum. 41(6):822–829CrossRef
3.
Metadata
Title
Scleroderma-associated cutaneous calcinosis: a remarkable regression post stem cell transplantation
Authors
Abuelmagd Abdalla
Muhammad Khalid
Qasim Ishaq
Suzanne Donnelly
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 2/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05368-x

Other articles of this Issue 2/2021

Clinical Rheumatology 2/2021 Go to the issue

Perspectives in Rheumatology

Dorsal root ganglia: fibromyalgia pain factory?

Review Article

Understanding the paradigm of non-radiographic axial spondyloarthritis

Letter to the Editor

Caution on the masqueraders of Good’s syndrome on thymoma with systemic lupus erythematosus

Letter to the Editor

COVID-19 vaccination in immunocompromised patients

Original Article

Cardiac valvular involvement of Takayasu arteritis

Original Article

Lower risk of primary Sjogren’s syndrome in patients with dengue virus infection: a nationwide cohort study in Taiwan
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits